Ultrasound in Medicine and Biology
Volume 35, Issue 7 , Pages 1217-1228 , July 2009

Detectability of Small Blood Vessels with High-Frequency Power Doppler and Selection of Wall Filter Cut-Off Velocity for Microvascular Imaging

  • Stephen Z. Pinter

      Affiliations

    • Biomedical Engineering Graduate Program, University of Western Ontario, London, Ontario, Canada
    • Robarts Research Institute, University of Western Ontario, London, Ontario, Canada
  • ,
  • James C. Lacefield

      Affiliations

    • Biomedical Engineering Graduate Program, University of Western Ontario, London, Ontario, Canada
    • Department of Electrical and Computer Engineering, University of Western Ontario, London, Ontario, Canada
    • Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
    • Robarts Research Institute, University of Western Ontario, London, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to: James C. Lacefield, Department of Electrical and Computer Engineering, University of Western Ontario, 279 Thompson Engineering Building, London, Ontario, N6A 5B9 Canada.

Received 12 September 2008 ,Revised 9 January 2009 ,Accepted 24 January 2009.

References 

  1. Browne JE, Watson AJ, Hoskins PR, Elliott AT. Validation of a sensitivity performance index test protocol and evaluation of colour Doppler sensitivity for a range of ultrasound scanners. Ultrasound Med Biol. 2004;30:1475–1483
  2. Burckhardt CB. The performance of mechanically scanned color flow mapping. Ultrason Imaging. 1989;11:227–232
  3. Cammarota T, Pinto F, Magliaro A, Sarno A. Current uses of diagnostic high-frequency US in dermatology. Eur J Dermatol. 1998;27:S215–S223
  4. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932–936
  5. Ferrara KW, Merritt CRB, Burns PN, Foster FS, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: Imaging, Doppler, and contrast agents. Acad Radiol. 2000;7:824–839
  6. Folkman J. Angiogenesis: An organizing principle for drug discovery?. Nature Rev Drug Discov. 2007;6:273–286
  7. Gabril MY, Onita T, Ji PG, Sakai H, Chan FL, Koropatnick J, et al. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model. Gene Therapy. 2002;9:1589–1599
  8. Goertz DE. Imaging the microcirculation with high frequency ultrasound. Ph.D. thesis, University of Toronto, 2002.
  9. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res. 2002;62:6371–6375
  10. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency 3-D color-flow imaging of the microcirculation. Ultrasound Med Biol. 2003;29:39–51
  11. Gudmundsson S, Valentin L, Pirhonen J, Olofsson PA, Dubiel M, Marsal K. Factors affecting color Doppler energy ultrasound recordings in an in vitro model. Ultrasound Med Biol. 1998;24:899–902
  12. Guyton AC. Textbook of medical physiology. Philadelphia, PA: Saunders; 1986;218–220
  13. Jain SP, Fan PH, Philpot EF, Nanda NC, Aggarwal KK, Moos S, et al. Influence of various instrument settings on the flow information derived from the power mode. Ultrasound Med Biol. 1991;17:49–54
  14. Jugold M, Palmowski M, Huppert J, Woenne EC, Mueller MM, Semmler W, et al. Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol. 2008;18:753–758
  15. Klabunde RE. Cardiovascular physiology concepts. Philadelphia, PA: Lippincott, Williams and Wilkins; 2005;91–93
  16. Kruse DE, Silverman RH, Fornaris RJ, Coleman DJ, Ferrara KW. A swept-scanning mode for estimation of blood velocity in the microvasculature. IEEE Trans Ultrason Ferroelectr Freq Control. 1998;45:1437–1440
  17. Magnin PA. A review of Doppler flow mapping techniques. IEEE Ultrason Symp Proc. 1987;969–977
  18. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH. Imaging angiogenesis: Applications and potential for drug development. J Natl Cancer Inst. 2005;97:172–187
  19. Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, et al. Evaluation of the effect of machine settings on quantitative three-dimensional power Doppler angiography: An in vitro flow phantom experiment. Ultrasound Obstet Gynecol. 2008;32:551–559
  20. Rosa N, Cennamo G, Breve MA, De Ruggiero P. Power Doppler ultrasonography in ocular and orbital diseases. Ophthalmologica. 1998;212:99–100
  21. Rubin JM, Adler RS, Fowlkes JB, Spratt S, Pallister JE, Chen JF, et al. Fractional moving blood volume: Estimation with power Doppler US. Radiology. 1995;197:183–190
  22. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS. Power Doppler US: A potentially useful alternative to mean frequency-based color Doppler US. Radiology. 1994;190:853–856
  23. Ryan LK, Foster FS. Tissue equivalent vessel phantoms for intravascular ultrasound. Ultrasound Med Biol. 1997;23:261–273
  24. Silverman RH, Kruse DE, Coleman DJ, Ferrara KW. High-resolution ultrasonic imaging of blood flow in the anterior segment of the eye. Invest Ophthalmol Vis Sci. 1999;40:1373–1381
  25. Xuan JW, Bygrave M, Jiang H, Valiyeva F, Dunmore-Buyze J, Holdsworth DW, et al. Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound. Cancer Res. 2007;67:2830–2839
  26. Zemp RJ, Abbey CK, Insana MF. Ideal observer model for detection of blood perfusion and flow using ultrasound. In: Lecture notes in computer science, Vol. 2732, Berlin: Springer-Verlag, 2003:318–329.
  27. Zemp RJ, Insana MF. Experimental validation of a power Doppler performance model. IEEE Ultrason Symp Proc. 2003;1:861–864

PII: S0301-5629(09)00031-3

doi: 10.1016/j.ultrasmedbio.2009.01.010

Ultrasound in Medicine and Biology
Volume 35, Issue 7 , Pages 1217-1228 , July 2009